ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
iPPS shows 3-year equivalent durability in OA Canine Study
Published: 01/06/23, 08:21am (AEST)•6 pages